Press Releases
Patheon to Showcase its Complex Formulation Technologies Expertise at CPhI/ICSE – Japan Conference
The global injectable drug delivery device technologies market was valued at approximately $10.2bn in 2012 and is expected to grow at a CAGR rate of...
Press Releases
Anton Paar Releases New MCP 100 Polarimeter
The new, extremely compact MCP 100 polarimeter now helps anyone working with optically active substances to reach all required targets in a fully traceable fashion....
Press Releases
Ferrer licenses commercialisation rights for Ozenoxacin in the United States to Medimetriks Pharmaceuticals Inc.
Ferrer, a privately-held Spanish pharmaceutical company today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in the United States of...
Press Releases
Provepharm¹s Japanese partner Daiichi Sankyo files an NDA to market the Methylene Blue injection medicinal product in Japan
Provepharm, a French company specialized in the development of pharmaceutical applications announces that Daiichi Sankyo, Co. Ltd., a global pharmaceutical firm, has filed an NDA ...
Press Releases
CiToxLAB appoints John C. Kapeghian as senior director of toxicology in North America
This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs. ...
Press Releases
Adocia announces preliminary positive clinical results for its combination of long-acting insulin Glargine and fast-acting insulin analog Lispro, Biochaperone(R) Combo
Adocia’s BioChaperone Combo is the first product combining insulin Glargine with a fast-acting insulin analogPhase I/II clinical trial demonstrates proof of concept in patients with...
Press Releases
UBM to Launch Southeast Asia’s Leading International Beauty Trade Show In Thailand
BANGKOK Feb. 25 2014 - UBM Asia is pleased to announce the launch of ASEANbeauty the only beauty trade event supported by the Thai Cosmetics...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.